Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation

Stock Information for Achieve Life Sciences Inc.

Loading

Please wait while we load your information from QuoteMedia.